These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 10497972)

  • 1. Blood-stage dynamics and clinical implications of mixed Plasmodium vivax-Plasmodium falciparum infections.
    Mason DP; McKenzie FE
    Am J Trop Med Hyg; 1999 Sep; 61(3):367-74. PubMed ID: 10497972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review and recent progress: the mathematical modeling of mixed species Plasmodium infections.
    Mason DP
    Southeast Asian J Trop Med Public Health; 2000; 31 Suppl 1():69-74. PubMed ID: 11414463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haematological response in experimental human Plasmodium falciparum and Plasmodium vivax malaria.
    Woolley SD; Marquart L; Woodford J; Chalon S; Moehrle JJ; McCarthy JS; Barber BE
    Malar J; 2021 Dec; 20(1):470. PubMed ID: 34930260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competition for red blood cells can enhance Plasmodium vivax parasitemia in mixed-species malaria infections.
    McQueen PG; McKenzie FE
    Am J Trop Med Hyg; 2006 Jul; 75(1):112-25. PubMed ID: 16837717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo responses to antimalarials by Plasmodium falciparum and Plasmodium vivax from isolated Gag Island off northwest Irian Jaya, Indonesia.
    Fryauff DJ; Sumawinata I; Purnomo ; Richie TL; Tjitra E; Bangs MJ; Kadir A; Ingkokusumo G
    Am J Trop Med Hyg; 1999 Apr; 60(4):542-6. PubMed ID: 10348226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody Responses to
    McLean ARD; Boel M; McGready R; Ataide R; Drew D; Tsuboi T; Beeson JG; Nosten F; Simpson JA; Fowkes FJI
    Am J Trop Med Hyg; 2017 May; 96(5):1197-1204. PubMed ID: 28500806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium vivax Malaria among military personnel, French Guiana, 1998-2008.
    Queyriaux B; Texier G; Ollivier L; Galoisy-Guibal L; Michel R; Meynard JB; Decam C; Verret C; Pommier de Santi V; Spiegel A; Boutin JP; Migliani R; Deparis X
    Emerg Infect Dis; 2011 Jul; 17(7):1280-2. PubMed ID: 21762587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmodium vivax in the Era of the Shrinking P. falciparum Map.
    Price RN; Commons RJ; Battle KE; Thriemer K; Mendis K
    Trends Parasitol; 2020 Jun; 36(6):560-570. PubMed ID: 32407682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preserved dendritic cell HLA-DR expression and reduced regulatory T cell activation in asymptomatic Plasmodium falciparum and P. vivax infection.
    Kho S; Marfurt J; Noviyanti R; Kusuma A; Piera KA; Burdam FH; Kenangalem E; Lampah DA; Engwerda CR; Poespoprodjo JR; Price RN; Anstey NM; Minigo G; Woodberry T
    Infect Immun; 2015 Aug; 83(8):3224-32. PubMed ID: 26034211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic.
    Poespoprodjo JR; Fobia W; Kenangalem E; Lampah DA; Warikar N; Seal A; McGready R; Sugiarto P; Tjitra E; Anstey NM; Price RN
    Clin Infect Dis; 2008 May; 46(9):1374-81. PubMed ID: 18419439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of Plasmodium falciparum and P. vivax infections on placental histopathology in an area of low malaria transmission.
    McGready R; Davison BB; Stepniewska K; Cho T; Shee H; Brockman A; Udomsangpetch R; Looareesuwan S; White NJ; Meshnick SR; Nosten F
    Am J Trop Med Hyg; 2004 Apr; 70(4):398-407. PubMed ID: 15100454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gametocytemia and fever in human malaria infections.
    McKenzie FE; Jeffery GM; Collins WE
    J Parasitol; 2007 Jun; 93(3):627-33. PubMed ID: 17626355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The high risk of malarial recurrence in patients with Plasmodium-mixed infection after treatment with antimalarial drugs: a systematic review and meta-analysis.
    Mahittikorn A; Masangkay FR; Kotepui KU; Milanez GJ; Kotepui M
    Parasit Vectors; 2021 May; 14(1):280. PubMed ID: 34034802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoresistance of Plasmodium falciparum and Plasmodium vivax parasites in Brazil: consequences on disease morbidity and control.
    Gama BE; Lacerda MV; Daniel-Ribeiro CT; Ferreira-da-Cruz Mde F
    Mem Inst Oswaldo Cruz; 2011 Aug; 106 Suppl 1():159-66. PubMed ID: 21881770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
    Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
    Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of a gradual dormancy concept in malaria.
    Richter J; Franken G; Holtfreter MC; Walter S; Labisch A; Mehlhorn H
    Parasitol Res; 2016 Jun; 115(6):2139-48. PubMed ID: 27079460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study.
    Llanos-Cuentas A; Casapia M; Chuquiyauri R; Hinojosa JC; Kerr N; Rosario M; Toovey S; Arch RH; Phillips MA; Rozenberg FD; Bath J; Ng CL; Cowell AN; Winzeler EA; Fidock DA; Baker M; Möhrle JJ; Hooft van Huijsduijnen R; Gobeau N; Araeipour N; Andenmatten N; Rückle T; Duparc S
    Lancet Infect Dis; 2018 Aug; 18(8):874-883. PubMed ID: 29909069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Pyronaridine-Artesunate for the Treatment of Uncomplicated
    Han KT; Lin K; Han ZY; Myint MK; Aye KH; Thi A; Thapa B; Bustos MD; Borghini-Fuhrer I; Ringwald P; Duparc S
    Am J Trop Med Hyg; 2020 Sep; 103(3):1088-1093. PubMed ID: 32524960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
    Deniskin R; Frame IJ; Sosa Y; Akabas MH
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy.
    Barber BE; William T; Grigg MJ; Menon J; Auburn S; Marfurt J; Anstey NM; Yeo TW
    Clin Infect Dis; 2013 Feb; 56(3):383-97. PubMed ID: 23087389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.